End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.03 CNY | -5.75% | -9.67% | -32.97% |
05-06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
04-26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
- Stock Market
- Equities
- 2315 Stock
- News Biocytogen Pharmaceuticals (Beijing) Co., Ltd.